Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53


Application of Bld-1-Embedded Elastin-Like Polypeptides in Tumor Targeting.

Sarangthem V, Cho EA, Yi A, Kim SK, Lee BH, Park RW.

Sci Rep. 2018 Mar 1;8(1):3892. doi: 10.1038/s41598-018-21910-z.


Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment.

Sharma S, Mann AP, Mölder T, Kotamraju VR, Mattrey R, Teesalu T, Ruoslahti E.

J Control Release. 2017 Dec 28;268:49-56. doi: 10.1016/j.jconrel.2017.10.006. Epub 2017 Oct 13.


Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth.

Sharma S, Kotamraju VR, Mölder T, Tobi A, Teesalu T, Ruoslahti E.

Nano Lett. 2017 Mar 8;17(3):1356-1364. doi: 10.1021/acs.nanolett.6b03815. Epub 2017 Feb 17.


Tumor-targeting peptides from combinatorial libraries.

Liu R, Li X, Xiao W, Lam KS.

Adv Drug Deliv Rev. 2017 Feb;110-111:13-37. doi: 10.1016/j.addr.2016.05.009. Epub 2016 May 19. Review. Erratum in: Adv Drug Deliv Rev. 2018 Mar 9;:.


Tumor penetrating peptides for improved drug delivery.

Ruoslahti E.

Adv Drug Deliv Rev. 2017 Feb;110-111:3-12. doi: 10.1016/j.addr.2016.03.008. Epub 2016 Apr 1. Review.


The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms.

Porcellini S, Asperti C, Valentinis B, Tiziano E, Mangia P, Bordignon C, Rizzardi GP, Traversari C.

Oncoimmunology. 2015 Jul 1;4(10):e1041700. eCollection 2015 Oct.


Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges.

Toporkiewicz M, Meissner J, Matusewicz L, Czogalla A, Sikorski AF.

Int J Nanomedicine. 2015 Feb 17;10:1399-414. doi: 10.2147/IJN.S74514. eCollection 2015. Review.


AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients.

Langlois B, Saupe F, Rupp T, Arnold C, van der Heyden M, Orend G, Hussenet T.

Oncotarget. 2014 Nov 15;5(21):10529-45.


Ligation strategies for targeting liposomal nanocarriers.

Marqués-Gallego P, de Kroon AI.

Biomed Res Int. 2014;2014:129458. doi: 10.1155/2014/129458. Epub 2014 Jul 14. Review.


Novel target for peptide-based imaging and treatment of brain tumors.

Hyvönen M, Enbäck J, Huhtala T, Lammi J, Sihto H, Weisell J, Joensuu H, Rosenthal-Aizman K, El-Andaloussi S, Langel U, Närvänen A, Bergers G, Laakkonen P.

Mol Cancer Ther. 2014 Apr;13(4):996-1007. doi: 10.1158/1535-7163.MCT-13-0684. Epub 2014 Feb 3.


Combinatorial peptide libraries: mining for cell-binding peptides.

Gray BP, Brown KC.

Chem Rev. 2014 Jan 22;114(2):1020-81. doi: 10.1021/cr400166n. Epub 2013 Dec 3. Review. No abstract available.


Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.

Agemy L, Kotamraju VR, Friedmann-Morvinski D, Sharma S, Sugahara KN, Ruoslahti E.

Mol Ther. 2013 Dec;21(12):2195-204. doi: 10.1038/mt.2013.191. Epub 2013 Aug 20. Erratum in: Mol Ther. 2014 Nov;22(11):2013.


Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example.

Corti A, Curnis F, Rossoni G, Marcucci F, Gregorc V.

BioDrugs. 2013 Dec;27(6):591-603. doi: 10.1007/s40259-013-0048-z. Review.


Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies.

Shukla GS, Krag DN, Peletskaya EN, Pero SC, Sun YJ, Carman CL, McCahill LE, Roland TA.

Cancer Immunol Immunother. 2013 Aug;62(8):1397-410. doi: 10.1007/s00262-013-1443-5. Epub 2013 Jun 5.


Mouse models for studying angiogenesis and lymphangiogenesis in cancer.

Eklund L, Bry M, Alitalo K.

Mol Oncol. 2013 Apr;7(2):259-82. doi: 10.1016/j.molonc.2013.02.007. Epub 2013 Mar 5. Review.


Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery.

Li ZJ, Cho CH.

J Transl Med. 2012 Sep 19;10 Suppl 1:S1. doi: 10.1186/1479-5876-10-S1-S1. Epub 2012 Sep 19. Review.


Affinity peptide developed by phage display selection for targeting gastric cancer.

Zhang WJ, Sui YX, Budha A, Zheng JB, Sun XJ, Hou YC, Wang TD, Lu SY.

World J Gastroenterol. 2012 May 7;18(17):2053-60. doi: 10.3748/wjg.v18.i17.2053.


Peptides as targeting elements and tissue penetration devices for nanoparticles.

Ruoslahti E.

Adv Mater. 2012 Jul 24;24(28):3747-56. doi: 10.1002/adma.201200454. Epub 2012 May 2. Review.


Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy.

Johansson A, Hamzah J, Payne CJ, Ganss R.

Proc Natl Acad Sci U S A. 2012 May 15;109(20):7841-6. doi: 10.1073/pnas.1118296109. Epub 2012 Apr 30.


Tumor endothelial cells.

Dudley AC.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006536. doi: 10.1101/cshperspect.a006536. Review.

Supplemental Content

Support Center